Skip to main content
Timothy Olsen, MD, Ophthalmology, Rochester, MN, Emory University Hospital

TimothyWOlsenMD

Ophthalmology • Rochester, MN

Retinal Disease

Founder and CEO, EyeMacular Regeneration, LLC

Join to view full profile

Dr. Olsen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Olsen's full profile

Already have an account?

Summary

  • Timothy W. Olsen MD is the founder and CEO of EyeMacular Regeneration, Inc. (December 2023) and iMacular Regeneration, LLC (June 2016). EyeMac Regen is developing novel therapies for end-stage macular disease and intraocular drug delivery. iMac Regen studies the pathogenesis of AMD and is based on the Minnesota Grading System (MGS). Translational research has been supported by NIH/NEI-STTR-SBIR grants. He has been awarded over $8.7M in total research support as a Principal Investigator, published over 196 peer-reviewed publications, and delivered over 485 national or international lectures. More recently, Dr. Olsen served as Professor and Consultant in Ophthalmology at the Mayo Clinic in Rochester, Minnesota (2017-2023), Secretary for Quality of Care for the American Academy of Ophthalmology (2016-2022) and as President ('23-24) of both the American Ophthalmological Society and the Minnesota Academy of Ophthalmology. At Emory, Dr. Olsen served as the F. Phinizy Calhoun Sr. Professor, Chairman of Ophthalmology, and Director of the Emory Eye Center (2007-2016). Prior to his time at Emory, he led the Minnesota Lions Macular Degeneration Center and director of Retina at the University of Minnesota ('98-07) where he became a full Professor on the tenure track. He began his academic career at the University of Wisconsin, Madison as Assistant Professor from 1996-1998. Olsen graduated summa cum laude from the University of Kansas and was selected AOA at KU Medical Center in Kansas City. He completed his residency at the University of Minnesota and Fellowship in Vitreoretinal Diseases and Surgery at Emory University in Atlanta.

Clinical Expertise

  • Pigment Epithelium of Eye, Macular degeneration, Vitreoretinal disease, Surgery, Intraocular tumors

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Surgical Retina and Vitreous, 1993 - 1996
  • University of Minnesota
    University of MinnesotaResidency, Ophthalmology, 1991 - 1993
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineInternship, Internal Medicine, 1989 - 1990
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1989
  • University of Kansas
    University of KansasB.A., Human Biology, Summa Cum Laude, 1981 - 1985

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2017 - 2025
  • GA State Medical License
    GA State Medical License 1994 - 2017
  • WI State Medical License
    WI State Medical License 1995 - 2001
  • IL State Medical License
    IL State Medical License 1995 - 1999
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • President American Ophthalmological Society (AOS)
  • President Minnesota Academy of Ophthalmology
  • Charter Inductee Retina Hall of Fame RHOF, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • In cases of symptomatic vitreomacular adhesion without full-thickness macular hole, do you tend to observe for spontaneous resolution or treat with jetrea (ocriplasmin...  
    Tornambe PE, Singer M, Olsen TW, London N, Ocular Surgery News, 10/1/2014
  • Chorioretinal folds: associated disorders and a related maculopathy  
    Olsen TW,Palejwala NV, Lee LB, Bergstrom CS, Yeh S, Am J Ophthalmol, 5/1/2014
  • Effect of Long-Chain omega-3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Random...  
    Writing Group for the ARG, Bonds DE, Harrington M, et al, JAMA Internal Medicine, 3/17/2014
  • Join now to see all

Books/Book Chapters

  • Ophthalmic Surgery in Medical Management of the Surgical Patient, A Textbook of Perioperative Medicine 
    Chapter: General Considerations in Opthalmic Surgery. 
    Page 693 - 695Payne JF, Hubbard GB, Olsen TWEditors: Lubin MF, Dodson TF, Winawer NH.Cambridge University PressEdition 5th,2013
  • Ophthalmic Surgery in Medical Management of the Surgical Patient, A Textbook of Perioperative Medicine 
    Chapter: Cataract Surgery. 
    Page 696 - 697Shah R, Kim JY, Olsen TWEditors: Lubin MF, Dodson TF, Winawer NH.Cambridge University PressEdition 5th,2013
  • Ophthalmic Surgery in Medical Management of the Surgical Patient, A Textbook of Perioperative Medicine 
    Chapter: Corneal Transplantation. 
    Page 679 - 700McKee Y, Shah R, Kim JY, Olsen TWEditors: Lubin MF, Dodson TF, Winawer NH.Cambridge University PressEdition 5th,2013
  • Join now to see all

Abstracts/Posters

  • Global Burden of Diabetic Retinopathy and Age-Related Macular Degeneration.
    Olsen TW, Global Vision Course, Rollins School of Public Health., 5/5/2014
  • Correlation between Visual Acuity and Spectral Domain Optical Coherence Tomography Findings in Birdshot Choriortinopathy Patients.
    Ho VY, Shantha FF, Forooghian C, Bergstrom C, Hubbard GB, Olsen TW, Patel P, Yeh S, ARVO, Seattle, WA, 5/8/2013
  • Macular Diseases other than AMD.
    Olsen TW, ARVO, Seattle, WA, 5/7/2013
  • Join now to see all

Lectures

  • Macular Surgery and Complications. 
    Orlando, FL - 10/20/2014
  • Future Treatments for AMD. 
    Chicago, IL - 10/19/2014
  • Suprachoroidal, Trans-scleral, and Microneedle Drug Delivery. 
    Chicago, IL - 10/19/2014
  • Join now to see all

Other

  • Consultants for Focal Points (Clinical Modules for Ophthalmologists); Pharmacotherapy Targeting Ocular Neovascularization (Comments to issues raised in the Review). 
    Olsen TW, Hartnett ME, American Academy of Ophthalmology
    9/1/2008

Press Mentions

  • Seeing Dramatic Results After a Frightening Eye Injury
    Seeing Dramatic Results After a Frightening Eye InjuryJune 14th, 2019
  • Business Innovation with an Eye on Improving Vision
    Business Innovation with an Eye on Improving VisionMarch 13th, 2019
  • IOL Selection Important in Patients with Retinal Disease
    IOL Selection Important in Patients with Retinal DiseaseJuly 18th, 2017
  • Join now to see all

Grant Support

  • Intraocular Aerosol Treatment for inhibition of Proliferative VitreoretinopathyNIH/NEI2014–Present
  • Age-Related Macular Degeneration: Choroidal Translocation Surgery in the Primate ModelAbraham J. and Phyllis Katz Foundation2013–Present
  • RO1EY022097NIH/NEI2013–Present
  • Age-Related Macular Degneration Grant: Choroidal Translocation Surgery in the Primate ModelR. Howard Dobbs Jr. Foundation2012–Present
  • A Tissue Support Structure (Macular O-Rings) for Reconstructing, Translocating, or Transplanting Three-Dimensional Submacular Tissue Organoids in Age Related Macular Degeneration (AMD)NIH/NEI2019–2020
  • Age-Related Macular Degeneration: Choroidal Translocation Surgery in the Primate Model.The Fraser Parker Foundation2012–2013
  • The Subproteome In Age-Related Macular DegenerationNational Institute On Aging2007–2008
  • The Subproteome In Age-Related Macular DegenerationNational Institute On Aging2004–2007

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Manager, iMacular Regeneration LLCStart-Up CompanyDisclosure: Minimal Financial Value (11-2016)2016 - Present

Dr. Timothy Olsen, Dr. Timothy Olsen, MD, Dr. T Olsen, Dr. Timothy W Olsen